Ganga Pharmaceuticals Ltd Financials

Ganga Pharmaceuticals Ltd Financial Statement

Ganga Pharmaceuticals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024
Revenue	1.60	TBA
Operating Expense	1.42	TBA
Net Profit	0.02	TBA
Net Profit Margin	1.25	TBA
Earning Per Share	0.05	TBA
EBIDTA	0.17	TBA
Effective Tax Rate	22.22	TBA

Particulars	Sep 2024
Revenue	1.60
Operating Expense	1.42
Net Profit	0.02
Net Profit Margin	1.25
Earning Per Share	0.05
EBIDTA	0.17
Effective Tax Rate	22.22

Ganga Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	2.74	2.59	2.49
Operating Expenses Annual	2.68	2.58	2.45
Operating Profit Annual	0.30	0.30	0.30
Interest Annual	0.18	0.19	0.19
Depreciation	0.05	0.06	0.05
Net Profit Annual	0.05	0.04	0.04
Tax Annual	0.02	0.01	0.01

Particulars	Mar 2024
Total Revenue Annual	2.74
Operating Expenses Annual	2.68
Operating Profit Annual	0.30
Interest Annual	0.18
Depreciation	0.05
Net Profit Annual	0.05
Tax Annual	0.02

Ganga Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.03	0.02	0.01
Cash Flow from Operations	-1.26	-0.04	-0.21
Cash Flow from Investing	0.13	0.49	0.19
Cash Flow from Financing	1.14	-0.44	0.03
Cash Flow at the End	0.03	0.03	0.02

Particulars	Mar 2024
Cash Flow at the Beginning	0.03
Cash Flow from Operations	-1.26
Cash Flow from Investing	0.13
Cash Flow from Financing	1.14
Cash Flow at the End	0.03

Ganga Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	10.58	11.58	12.05
PBIT Margin (%)	8.76	9.27	10.04
PBT Margin (%)	-41.97	-39.38	-40.56
Net PROFIT Margin (%)	1.82	1.54	1.61
Return On Networth / Equity (%)	0.80	0.74	0.74
Return On Networth /Employed (%)	3.18	3.28	3.32
Return On Assets (%)	0.64	0.54	0.55
Total Debt / Equity (X)	0.25	0.35	0.34
Asset Turnover Ratio (%)	0.35	0.35	0.34

Particulars	Mar 2024
PBDIT Margin (%)	10.58
PBIT Margin (%)	8.76
PBT Margin (%)	-41.97
Net PROFIT Margin (%)	1.82
Return On Networth / Equity (%)	0.80
Return On Networth /Employed (%)	3.18
Return On Assets (%)	0.64
Total Debt / Equity (X)	0.25
Asset Turnover Ratio (%)	0.35

Ganga Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	0.61	0.64	0.68
Total Current Assets Annual	5.75	5.15	4.91
Non Current Assets Annual	2.90	2.84	3.09
Total Shareholders Funds Annual	7.05	5.45	5.41
Total Assets Annual	8.65	7.98	8.00

Particulars	Mar 2024
Fixed Assets Annual	0.61
Total Current Assets Annual	5.75
Non Current Assets Annual	2.90
Total Shareholders Funds Annual	7.05
Total Assets Annual	8.65

Ganga Pharmaceuticals Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 26, 2024, Ganga Pharmaceuticals Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Ganga Pharmaceuticals Ltd is debt-free with a debt-to-equity ratio of 0.19.

In FY 2023 , Ganga Pharmaceuticals Ltd recorded a total revenue of approximately 2.74 Cr marking a significant milestone in the company's financial performance.

Ganga Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -100.0% and 0.0% annually, respectively..

Ganga Pharmaceuticals Ltd's current PE ratio is undefined.

Ganga Pharmaceuticals Ltd's ROCE averaged 3.3% from the FY ending March 2022 to 2024, with a median of 3.4%. It peaked at 3.5% in March 2023, reflecting strong capital efficiency over the period..

Ganga Pharmaceuticals Ltd's latest EBIT is Rs. 0.24 Cr, surpassing the average EBIT of Rs. 0.24 Cr over the 5 years..